DeepEcho, a winner of the Cure Xchange Challenge 2023: Health AI for Good

Deepecho is proud to announce its victory at the Cure Xchange Challenge: Health AI for Good 2023, a significant milestone that underscores the company’s unwavering commitment to revolutionizing prenatal care through innovative technology. This awards not only highlights Deepecho’s leading-edge artificial intelligence software but also serves as a testament to the remarkable strides being made in the field of health technology, specifically within the crucial arena of fetal healthcare.

The ceremony, held on February 22, 2024, was not just a celebration of Deepecho’s technological innovation but also a moment to highlight the potential of collaborative efforts in advancing healthcare. Co-Founder Saad Slimani, received the award in the presence of notable figures Seema Kumar and Chelsea Clinton, symbolizing the collective aspiration to leverage AI for the betterment of global prenatal care equity.

Deepecho’s win extends beyond the prestige of the award. As part of the recognition, Deepecho will benefit from a comprehensive support package designed to amplify its impact in the healthcare sector. This includes a residency at Cure’s state-of-the-art innovation campus in New York City, seed money, mentorship, and access to the Cure ecosystem for enhanced developmental support. This support is aimed at accelerating Deepecho’s development and enhancing its capabilities in advancing fetal health diagnostics through AI.

Deepecho’s work is particularly significant in the context of global health challenges. The company’s focus on making critical screenings for conditions including preeclampsia and fetal growth restriction accessible to all is a commendable effort towards reducing fetal and maternal mortality rates worldwide. By mimicking the expertise of trained sonographers, Deepecho’s AI and deep learning technologies provide valuable support to radiologists and clinicians, enabling more accurate and timely diagnosis.

Cure’s mission goes beyond providing physical space and resources. It aims to lead and shape the future of healthcare through industry-leading event programming focused on critical health topics. This aligns with Deepecho’s vision of leveraging technology to address healthcare challenges, making the partnership between the two entities a powerful force for innovation in healthcare.

ABOUT CURE®

Located in New York City, Cure’s 300,000-square-foot campus is a hub for health innovation, equipped with state-of-the-art wet labs, event spaces, and collaborative areas. It supports over 20 startups and companies, fostering development in diagnostics, medical devices, pharmaceuticals, and vaccines. Designed for interdisciplinary collaboration and idea exchange, Cure has become a key site for networking and professional growth, organizing over 40 industry events since 2021 that attract thousands of leaders in healthcare. The campus houses a diverse range of residents, including both for-profit and non-profit organizations focused on advancing medical technology, healthcare services, therapeutics, and investment, positioning Cure at the forefront of healthcare innovation and partnership. This vibrant ecosystem not only catalyzes technological and therapeutic breakthroughs but also cultivates a community of pioneers committed to reshaping the future of health.

For more information, please visit : https://wewillcure.com/.

Cure Media Contact:

Caroline Drucker
cdrucker@cureexperience.com
(917) 588-3016